Barinthus Biotherapeutics Barinthus Biotherapeutics (formerly known as Vaccitech) is a T-cell immunotherapy company developing products to treat and prevent cancer and infectious diseases. | ||
Founding Date | Founding Date 2016 | Founding Date 2014 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Oxford, GB HQ | Locations Redmond, US HQ |
Employees | Employees 33 | Employees 841% increase |
Funding | ||
Total funding raised | Total funding raised $ 195.1m | Total funding raised $ 76m |

Systimmune is a biopharmaceutical company focused on the treatment of cancer.
View company